Genetics of graft-versus-host disease, I. A locus on chromosome 1 influences development of acute graft-versus-host disease in a major histocompatibility complex mismatched murine model

Immunology

Volumn 96, Issue 2, 1999, Pages 254-261

  Allen, R D ^a   Dobkins, J A ^a   Harper, J M ^a   Slayback, D L ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CHROMOSOME 1; CHROMOSOME 4; CONTROLLED STUDY; DISEASE SEVERITY; EFFECTOR CELL; EXPERIMENTAL TRANSPLANTATION; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; GENETIC POLYMORPHISM; GRAFT VERSUS HOST REACTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLENOMEGALY;

ACUTE DISEASE; ANIMALS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 4; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; HUMANS; HYBRIDIZATION, GENETIC; LINKAGE (GENETICS); LOD SCORE; MICE; MICE, INBRED DBA; MICE, INBRED STRAINS; ORGAN SIZE; POLYMORPHISM, GENETIC; SPLEEN; SPLENOMEGALY; STATISTICS, NONPARAMETRIC;

EID: 0032897029     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00626.x     Document Type: Article

References (35)

1. 1. TURNER D.M., WILLIAMS D.M., SANKARAN D., LAZARUS M., SINNOTT P.J. & HUTCHINSON I.V. (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogen 24, 1.
2. 2. WALLEY A.J. & COOKSON W.O. (1996) Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy. J Med Genet 33, 689.
3. 3. BAILLY S., DI GIOVINE F.S., BLAKEMORE A.I. & DUFF G.W. (1993) Genetic polymorphism of human interleukin-1 alpha. Eur J Immunol 13, 1240.
4. 4. BIOQUE G., CRUSIUS J.B.A., KOUTROUBAKIS I. et al. (1995) Allelic polymorphism in interleukin-1 beta and interleukin-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease.Clin Exp Immunol 102, 379.
5. 5. MATESANZ F. & ALCINA A. (1996) Glutamine and tetrapeptide repeat variations affect the biological activity of different mouse interleukin-2 alleles. Eur J Immunol 26, 1675.
6. 6. VERJANS G.M., MESSER G., WEISS E.H., VAN DER LINDEN S.M. & KULSTRA A. (1992) Polymorphism of the tumor necrosis factor region in relation to disease: an overview. Rheumatic Dis Clin North Am 18, 177.
7. 7. BLAKEMORE A.I., COx A., GONZALEZ A.M. et al. (1996) Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet 97, 369.
8. 8. DUFF G.W. (1994) interleukin-1 receptor antagonist and genetic susceptibility to inflammation. J Interferon Res 14, 305.
9. 9. VIA C.S. & SHEARER G.M. (1988) T cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol Today 9, 207.
10. 10. FAST L.D. (1990) Identification ofa single non-H-2 gene regulating graft-versus-host disease response. J Immunol 144, 4177.
11. 11. VAN ELVEN E.H., ROLINK A.G., VAN DER VEEN F. & GLEICHMANN E. (1981) Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease. J Exp Med 153, 1474.
12. 12. ALLEN R.D., STALEY T.A. & SIDMAN C.L. (1993) Differential cytokine expression in acute and chronic murine graft-versus-host disease. Eur J Immunol 23, 333.
13. 13. GARLISI C.G., PENNLINE K.J., SMITH S.R., SIEGAL M.I. & UMLAND S.P. (1993) Cytokine gene expression in mice undergoing chronic graft-versus-host disease. Mol Immunol 30, 669.
14. 14. DE WIT D., VAN MECHELIN M., ZANIN C. et al. (1993) Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol 150, 361.
15. 15. VIA C.S., RUS V., GATELY M.K. & FINKELMAN F.D. (1994) IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. J Immunol 153, 4040.
16. 16. DIETRICH W., KATZ H., LINCOLN S.E. et al. (1992) A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131, 423.
17. 17. HOGAN B., BEDDINGTON R., COSTANTINI F. & LACEY E. (1995) Manipulating the Mouse Embryo. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
18. 18. CHURCHILL G.A. & DOERGE R.W. (1994) Empirical threshold values for quantitative trait mapping. Genetics 138, 963.
19. 19. MANLY K. (1998) Map Manager QT. World Wide Web (URL: http://mcbio.med.buffalo.edu/mmQT.html), March.
20. 20. PALS S.T. & GLEICHMANN E. (1983) A sequential alloactivation of subsets of donor T cells underlies the transition from acute graft-versus-host disease (GVHD) to chronic GVHD. Trans Proc 15, 1480.
21. 21. KORNGOLD R. & SPRENT J. (1987) Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice. J Exp Med 165, 1552.
22. 22. ROLINK A.G., PALS S.T. & GLEICHMANN E. (1983) Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A. J Exp Med 157, 755.
23. 23. MOUSE GENOME DATABASE (MGD) (1998) Mouse Genome Informatics. The Jackson Laboratory, Bar Harbor Maine, World Wide Web (URL: http://www.informatics.jax.org/), March.
24. 24. MULUK S.C., HAKIM F.T. & SHEARER G.M. (1992) Regulation of graft-versus-host-reaction by Mlsa-reactive donor T cells. Eur J Immunol 22, 1967.
25. 25. MANN R.A., SINGH A.B., SINGH M. & JETZT A.E. (1993) The host response in graft versus host disease. II. The emergence of host protective cells is in part determined by background genomic compatibility. Cell Immunol 151, 39.
26. 26. JONES M.S., RILEY R., HAMILTON B.L., PAUPE J., PEREZ D. & LEVY R.B. (1994) Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma. Bone Marrow Transplant 14, 725.
27. 27. MICONNET I., ROGER T., SEMAN M. & BRULEY-ROSSET M. (1995) Critical role of endogenous Mtv in acute lethal graft-versus-host disease. Eur J Immunol 25, 364.
28. 28. GOLLOB K.J., NAGELKERKEN L. & COFFMAN R.L. (1993) Endogenous retroviral superantigen presentation by B cells induces the development of type 1, CD4+ T helper lymphocytes. Eur J Immunol 23, 2565.
29. 29. SCOTT B., LIBLAU R., DEGERMANN S. et al. (1994) A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1, 73.
30. 30. BIANCONE L., ANDRES G., AHN H. et al. (1996) Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type-2 mediated autoimmune disease. J Exp Med 183, 1473.
31. 31. GOLLOB J.A., LI J., KAWASAKI H. et al. (1996) Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12. J Immunol 157, 1886.
32. 32. GOLLOB J.A. & RITZ, J. (1996) CD2 CD58 interaction and the control of T-cell interleukin-12 responsiveness. Adhesion molecules link innate and acquired immunity. Ann N Y Acad Sci 795, 71.
33. 33. DEL PRETE G., DE CARLI M., D'ELIOS M.M. et al. (1995) CD30-mediated signaling promotes the development of human T helper type 2-like T cells. J Exp Med 182, 1655.
34. β2 positive T-lymphocytes. Ann N Y Acad Sci 756, 113.
35. 35. CONRAD B., WEISSMAHR R.N., BONI J., ARCARI R., SCHUPBACH J. & MACH B. (1997) A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 90, 303.